Ingredion Incorporated $INGR Shares Sold by Yacktman Asset Management LP

Yacktman Asset Management LP lessened its stake in Ingredion Incorporated (NYSE:INGR) by 1.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,423,654 shares of the company’s stock after selling 18,432 shares during the quarter. Ingredion accounts for about 2.2% of Yacktman Asset Management LP’s portfolio, making the stock its 14th largest holding. Yacktman Asset Management LP’s holdings in Ingredion were worth $156,972,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of INGR. Integrated Wealth Concepts LLC lifted its holdings in shares of Ingredion by 32.8% in the 1st quarter. Integrated Wealth Concepts LLC now owns 2,082 shares of the company’s stock valued at $281,000 after buying an additional 514 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Ingredion by 63.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,694 shares of the company’s stock valued at $499,000 after buying an additional 1,440 shares during the period. NewEdge Advisors LLC lifted its holdings in shares of Ingredion by 9.0% in the 1st quarter. NewEdge Advisors LLC now owns 9,687 shares of the company’s stock valued at $1,310,000 after buying an additional 797 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of Ingredion by 5.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 101,414 shares of the company’s stock valued at $13,712,000 after buying an additional 5,255 shares during the period. Finally, Focus Partners Wealth lifted its holdings in shares of Ingredion by 5.6% in the 1st quarter. Focus Partners Wealth now owns 3,636 shares of the company’s stock valued at $492,000 after buying an additional 192 shares during the period. Institutional investors and hedge funds own 85.27% of the company’s stock.

Insiders Place Their Bets

In other Ingredion news, CEO James P. Zallie sold 9,958 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $116.55, for a total transaction of $1,160,604.90. Following the completion of the sale, the chief executive officer directly owned 33,011 shares in the company, valued at approximately $3,847,432.05. The trade was a 23.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Davida Marie Gable sold 375 shares of the business’s stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $112.44, for a total value of $42,165.00. Following the sale, the vice president owned 7,110 shares of the company’s stock, valued at approximately $799,448.40. This trade represents a 5.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 48,686 shares of company stock worth $5,784,010. Corporate insiders own 1.60% of the company’s stock.

Ingredion Stock Performance

NYSE INGR opened at $107.43 on Friday. The stock has a market capitalization of $6.77 billion, a price-to-earnings ratio of 10.35, a PEG ratio of 0.87 and a beta of 0.64. Ingredion Incorporated has a twelve month low of $100.71 and a twelve month high of $141.78. The company has a current ratio of 2.76, a quick ratio of 1.73 and a debt-to-equity ratio of 0.40. The stock has a 50-day moving average of $112.69 and a 200 day moving average of $112.88.

Ingredion (NYSE:INGR) last released its quarterly earnings results on Tuesday, May 5th. The company reported $2.34 earnings per share for the quarter, missing analysts’ consensus estimates of $2.44 by ($0.10). The business had revenue of $1.79 billion during the quarter, compared to analyst estimates of $1.79 billion. Ingredion had a return on equity of 15.86% and a net margin of 9.36%.The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.97 EPS. Ingredion has set its FY 2026 guidance at 10.450-11.150 EPS. Sell-side analysts anticipate that Ingredion Incorporated will post 11.24 EPS for the current fiscal year.

Ingredion Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 21st. Shareholders of record on Wednesday, April 1st were paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 3.1%. The ex-dividend date was Wednesday, April 1st. Ingredion’s payout ratio is 31.60%.

Analyst Ratings Changes

INGR has been the subject of several analyst reports. Barclays decreased their price objective on Ingredion from $128.00 to $120.00 and set an “equal weight” rating for the company in a report on Wednesday. Weiss Ratings reissued a “hold (c)” rating on shares of Ingredion in a report on Friday, March 27th. Benchmark assumed coverage on Ingredion in a report on Tuesday, March 17th. They issued a “buy” rating and a $130.00 price target for the company. UBS Group reaffirmed a “neutral” rating and issued a $114.00 price target on shares of Ingredion in a report on Thursday. Finally, Jefferies Financial Group reaffirmed a “hold” rating on shares of Ingredion in a report on Wednesday, February 4th. Two analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $122.43.

Ingredion Profile

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.